HENDERSON, Nev.--(BUSINESS WIRE)--Spectrum Pharmaceuticals (NasdaqGS: SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in oncology and hematology, announced today that an overview of the Company’s business strategy will be given at the Jefferies 2011 Global Healthcare Conference, being held in London, England. The Spectrum Pharmaceuticals presentation is at 10:00 am local time on Wednesday, September 28, 2011.
